TL;DR
This study directly compares two radiotracers, Tc-99m DPD and Tc-99m PYP, for diagnosing cardiac amyloidosis (CA). While PYP scintigraphy appears more sensitive for detecting CA involvement, DPD scintigraphy seems to better reflect the disease's severity.
What Problem Does This Paper Address?
Cardiac amyloidosis (CA) is a serious condition where abnormal proteins deposit in the heart, leading to restrictive cardiomyopathy and a poor prognosis. Early and accurate diagnosis is crucial for effective treatment. Currently, several non-invasive methods exist, including electrocardiography, echocardiography, cardiac biomarkers, and nuclear medicine imaging. Among nuclear imaging techniques, Tc-99m 3,3-diphosphono-1,2-propanodicarboxylic acid (DPD) and Tc-99m sodium pyrophosphate (PYP) are the most commonly used radiotracers for evaluating CA, particularly the transthyretin amyloidosis (ATTR) subtype. However, despite their widespread use, no studies have directly compared the diagnostic and clinical utility of DPD and PYP scintigraphy in patients with CA. This lack of direct comparison leaves clinicians without clear guidance on which radiotracer might be superior for different aspects of CA assessment.
Methods
The researchers conducted a retrospective study involving 10 patients diagnosed with cardiac amyloidosis. These patients had undergone both DPD and PYP scintigraphy within a six-month period. The study employed two main types of analysis:
- Scintigraphic Parameter Analysis:
- Visual Scoring: Two established visual scoring systems, the Perugini and Dorbala systems, were used to assess myocardial radiotracer uptake. These systems categorize uptake from 0 (no uptake) to 3 (strong uptake), with specific criteria for each score.
- Semi-Quantitative Analysis: Four heart retention ratios were calculated from whole-body planar images: heart/whole-body profile (H/WBp), heart/pelvis (H/P), heart/skull (H/S), and heart/contralateral lung (H/CL). These ratios quantify the amount of radiotracer taken up by the heart relative to other body regions.
- Clinical Variable Assessment: Eight clinical variables were collected for each patient, including age, sex, estimated glomerular filtration rate (eGFR), NT-proBNP levels, and the results of electromyography (EMG), a quantitative sensory test, electrocardiogram (ECG), and echocardiography (EchoCG). Abnormal findings in EMG, sensory tests, ECG, and EchoCG were converted into dichotomous variables.
Comparative analyses were performed to assess correlations between DPD and PYP parameters, between visual scores and retention ratios, and between scintigraphic parameters and clinical variables. Statistical methods included the Shapiro-Wilk test for normality, Mann-Whitney U test for comparing groups, Fisher's exact test for discrete variables, and Spearman's correlation for linear relationships.
Datasets
Not discussed in the paper. The study used data from 10 patients diagnosed with cardiac amyloidosis at Samsung Medical Center.
Key Insights and Ideas
- DPD vs. PYP: A Tale of Two Strengths: The study suggests a complementary role for DPD and PYP. DPD appears better at reflecting the severity of CA, showing more associations with clinical markers of disease burden. PYP, on the other hand, seems more sensitive in detecting the presence of CA involvement.
- Visual Scoring Systems: Perugini vs. Dorbala: The Perugini system showed stronger correlations with quantitative retention ratios in both DPD and PYP scans. However, the Dorbala system was found to better reflect disease severity, aligning more closely with clinical variables.
- DPD's Deeper Clinical Connections: DPD parameters demonstrated significantly more associations with clinical variables (age, eGFR, NT-proBNP, EchoCG, EMG) compared to PYP parameters. This indicates DPD's findings are more closely tied to the patient's overall clinical status.
- PYP's Higher Uptake Tendency: Visual scores in PYP scans tended to be higher than in DPD scans, with more patients showing moderate to severe uptake on PYP. This hints at PYP's greater sensitivity in picking up even subtle cardiac involvement.
Key Results
- Retention Ratios: Significant correlations were observed across all four heart retention ratios (H/WBp, H/P, H/S, H/CL) between DPD and PYP scans, indicating a general agreement in quantifying cardiac uptake.
- Visual Scores: Perugini scores showed a significant correlation between DPD and PYP scans, while Dorbala scores did not.
- DPD vs. Clinical Variables: 20 DPD parameters showed significant associations with clinical variables, compared to only 9 PYP parameters.
- PYP Visual Scores: A higher proportion of patients showed higher visual scores (2 or more) on PYP scans compared to DPD scans, suggesting greater sensitivity for PYP.
- Severity Reflection: DPD parameters were more frequently associated with clinical variables like age, eGFR, NT-proBNP, EchoCG, and EMG, suggesting DPD better reflects disease severity.
Limitations and Future Work
- Retrospective and Single-Center: The study's retrospective nature and reliance on a single center limit its generalizability. A prospective, multi-center study is recommended.
- Small Sample Size: The small sample size (10 patients) may have limited statistical power.
- Dominance of ATTR CA: The study population was predominantly ATTR CA (90%), with only one AL CA patient. This limits conclusions regarding AL CA.
- Planar Scintigraphy Only: The study used planar scintigraphy, not SPECT/CT. Future work should include direct comparisons of DPD and PYP SPECT/CT, as planar imaging can sometimes misclassify uptake.
- Future Directions: The authors suggest validating these findings in larger, prospective studies and exploring the role of SPECT/CT for a more comprehensive comparison. Further research could also investigate the specific clinical scenarios where one radiotracer might be preferred over the other.
Summary updated